Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hello Q,
A long time since I have seen you on a ticker I am in. I would have done this in a private message, but unable. Not sure you remember me from our exchanges back in 2018 about O**I. I appreciate those exchanges even though we were opposite in opinion as you were professional.
However, that said, I have to say that you were right and I was wrong, I fell for the con. Lesson learned, hopefully.
Hope all is well and that we all do well here.
Zeus
Exactly how much junk do you have where you use a 10 foot pole to touch it with?
Absolutely, very exciting!
My bad, you are correct. Thanks for clarifying, I acted before digesting it.
New announcement Tueday, next week, 9/14.
New Tweet:
$PHIL Details for the announcement will be provided by Tuesday, 9-14. We want to thank you for your continued support and to let you know that our commitment to creating value for our shareholders has never been stronger! God Bless!!”
— PHI GROUP INC (@PHIGROUP) September 10, 2021
On contingency or not, experts are almost always hired by the lawyers. Contingency can mean several things, I think most seem to believe it is all encompassing, which is not likely the case not being class action. Could be contingency applies to the lawyers fees which has been my experience, and all expenses like expert, investigative measures, filing fees etc. are not covered under the contingency agreement. Just one person's opinion for what its worth.
The lower it goes, the more I buy. It's called opportunity!
Thats pretty good as 90% of all patent infringement cases settle before entering the claim construction stage and 95%-97% before going to court. The settlement rate is so high because if the plaintiff does not win all issues in each stage they lose entirely. In my mind if HCMC case is good, it behooves PM to settle to mitigate risk of a very large payout. It also makes sense for HCMC to settle to avoid the risk of total loss and instead ensure they walk away with money in the coffer. I think it largely comes down to what will the parties settle on and at what stage of the process. But hey, they may go for gusto. We will have to wait and see, GLTA
Yes, but then the toilet refills!
CBDD Congratulations my friend, you deserve it. We will be the beneficiaries of your retirement in having you here with us more often.
VSYM No worries, happens. Just wondering if I was missing something. Thanks for the clarification.
I only have 1.3 mil in here, but I think I will wait it out and see what happens. Will not have been the worst decision I will have ever made if it tanks and never returns. Might buy if able, if it goes down. We'll see. GLTA
Your last two post seem to contradict themselves, if there is no business or CEO, who is filing for the seed license. Please clarify.
HCMC Interesting, I don't use them, but that's what it says. Maybe they haven't updated the website in awhile. At least it's working for you, that's all that matters gl
Per their website they do not accept buy orders for OTC and pink sheet stocks that trade under 10 cents.
PCYT Thanks, watching the L2 I did not think it would fill, ask got down to about 38m, so I figured I better change and get in at .0004 before it possibly went up a tick, but my order was gone, it executed at 3 before I was able to change it. Close call. GLTA
PYCT Yeah, pretty lucky, did not think it would happen as my earlier block of 1.7m did not work out, so I bought those at .0004. Now we wait for lift off. GLTA
PYCT I'm finally in, got my 10M filled at .0003. Ready to ride.
CBDD Good morning Briz and all, looking good this morning! Exciting time to be in CBDD!
Article from yesterday"Best cannabis stocks trading less than a $1 (2021).
Yep, CBDD is one of them.
https://listblender.com/2021/01/18/best-cannabis-stocks-trading-less-than-1-2021/
To many factors to say for sure as it depends on the strength of the evidence the the plaintiffs have as well as the financial ability to stay the course against a large corporation. My guess is that it will never go to court, the defendants will attempt to delay as long as possible to drain the plaintiffs financially. If the evidence is solid and strong; providing plaintiffs have the financial staying power, it will settle out of court. If the evidence is truly accurate and solid, defendants will not allow it to actually go to trial as the potential loss could then be greater than a settlement. But like I said, to many factors to realistically call one way or another. Just my opinion however.
FWIW, Barcart has CBDD at 100% buy!
Looking forward to the ride my friend.
While I am sure that this article was posted earlier, it's not necessarily the contents of the article that intrigues me, but that the fact that CBDD is part of the article.
YCBD is trading at $2.71
MJNA is at .0145
CBGL .125
CWBHF $3.43
and CBDD sitting at .0011
1,318% lower than the closest price ticker in the article. What catches my attention is that CBDD is in the article with these other stocks. There are many other CBD plays out there, but CBDD was included, and for me that is rather telling. I'm not saying that we will see dollars per share from CBDD, but I am also not ruling it out. While CBDD is trading in the pee-wee league, it appears it is being recognized for potential play in the major leagues. It has the appearance that they are doing something right and regardless of the various types of manipulation being engaged, CBDD has all the markings of not only a legitimate business, but a real chance at a play in the big league.
MARIJUANA STOCK
MENU
WHY CBD STOCKS ARE RISING STARS (YCBD, MJNA, CBGL, CBDD, CWBHF)
BY ADMIN / FEATURE ARTICLE / 10 AUG 2020
Why CBD Stocks are Rising Stars (YCBD, MJNA, CBGL, CBDD, CWBHF)
With all the hoopla over the cannabis market, its younger brother is a more promising star: CBD. The CBD market wins over the cannabis market because it doesn’t have any hurdles to jump – that means legal or cultural – on its way to billions in total global sales. It just needs greater visibility.
Cannabis is expected to grow by leaps and bounds, but it suffers from both legal and cultural pushback. It isn’t just about legality here. Decades of disinformation and legacy norm boundaries have dealt cannabis a heavy toll in the PR department, and that ground isn’t easy to make up in a hurry.
But none of that exists in any important way for CBD because all of that is really about THC. Furthermore, there are other “innocent” cannabinoids to talk about next, including CBG, CBN, THCV, CBDA, etc. Each can get in line for its own coming out party over coming years.
But the winner right now, according to experts and analysts, is CBD. One recent piece of research (May 2020, Industryresearch.biz) for strictly CBD oil shows growth expectations at a CAGR of roughly 32.0% over the next five years, to reach over $1.25 billion by 2024, up from $311.8 million in 2019. These numbers are smaller simply because this is the market for CBD by itself. The market for CBD-based products is much larger, and will grow to be many times this size over the same period, with analysts calling for $15-25 billion in sales by 2025. Grand View Research, for example, puts the global cannabidiol-based products market at a value of $4.6 billion already by 2018. Their research suggests it will grow by over 22% CAGR from 2019 to 2025 to reach nearly $19 billion.
With that in mind, we take a look at a selection of active CBD stocks, including cbdMD Inc (NYSEAMERICAN:YCBD), Medical Marijuana Inc (OTCMKTS:MJNA), Cannabis Global Inc (OTCMKTS:CBGL), CBD of Denver Inc (OTCMKTS:CBDD), and Charlotte’s Web Holdings Inc (OTCMKTS:CWBHF).
cbdMD Inc (NYSEAMERICAN:YCBD) owns and operates the consumer hemp-based CBD brand, cbdMD. The company’s product categories include CBD tinctures, capsules, gummies, bath bombs, topical creams, and animal treats and oils.
It also offers pet related CBD products under the Paw CBD brand name. The company distributes its products through an e-commerce Website, wholesalers, and various brick and mortar retailers in the United States.
cbdMD Inc (NYSEAMERICAN:YCBD) just announced that its pet CBD brand, Paw CBD, has seen an approximate 64% increase in net sales from its March 2020 quarter of approximately $750,000 to approximately $1,229,000 for its June 2020 quarter.
“Paw CBD was launched less than one year ago, and now it is one of America’s leading CBD pet brands,” said Ken Cohn, CMO of cbdMD, Inc. “Sales metrics are all moving in the right direction, with Paw CBD now trending at over a $7mm annualized run rate, and cbdMD’s overall direct-to-consumer (DTC) sales making up over 70% of the brand’s revenue. We are seeing the DTC power of cbdMD.com translating into significant growth for PawCBD.com.”
The context for this announcement is a bit of a bid, with shares acting well over the past five days, up about 11% in that timeframe. Shares of the stock have powered higher over the past month, rallying roughly 54% in that time on strong overall action.
cbdMD Inc (NYSEAMERICAN:YCBD) pulled in sales of $9.4M in its last reported quarterly financials, representing top line growth of 65.7%. In addition, the company has a strong balance sheet, with cash levels far exceeding current liabilities ($14.9M against $5.8M).
Medical Marijuana Inc (OTCMKTS:MJNA) bills itself as an investment holding company that operates in the medical marijuana and industrial hemp markets, including CBD products. Its products range from patented and proprietary based cannabinoid products to seed and stalk or isolated high value extracts manufactured and formulated for the pharmaceutical, nutraceutical, and cosmeceutical industries. The company licenses its proprietary testing, genetics, labeling and packaging, tracking, production, and standardization methods for the medicinal cannabinoid industry.
It engages in the research and development of cannabinoid-based pharmaceuticals; and marketing and distribution of cannabidiol hemp oil-based products. In addition, the company provides management support and services to cooperatives, collectives, health and wellness facilities, and medical clinics, and consulting and securities services to businesses and individuals in the legal cannabis industry.
Medical Marijuana Inc (OTCMKTS:MJNA) just recently announced that its subsidiary Kannaway is proud to support the European Industrial Hemp Association (EIHA) in its recent opinion letter to the European Commission on the legal status of cannabidiol (CBD) and hemp.
EIHA’s letter was written in response to the European Commission’s decision to suspend all applications for hemp extracts and natural cannabinoids under the European Union’s Novel Food rules and also deem under a “preliminary conclusion” that extracts from the flowering and fruiting tops of the hemp plant should be considered a drug under the United Nations Single Convention on Narcotic Drugs of 1961. EIHA explains that the decision is “not based on the latest scientific literature nor inspired by the current debate at the United Nations level.”
Even in light of this news, MJNA has had a rough past week of trading action, with shares sinking something like -5% in that time. That said, chart support is nearby, and we may be in the process of constructing a nice setup for some movement back the other way. Over the past month, shares of the stock have suffered from clear selling pressure, dropping by roughly -13%.
Medical Marijuana Inc (OTCMKTS:MJNA) managed to rope in revenues totaling $13.4M in overall sales during the company’s most recently reported quarterly financial data — a figure that represents a rate of top line growth of -34%, as compared to year-ago data in comparable terms. In addition, the company is battling some balance sheet hurdles, with cash levels struggling to keep up with current liabilities ($5M against $11.1M, respectively).
Cannabis Global Inc (OTCMKTS:CBGL) is one of the most interesting and possibly undervalued names in the space given its strong IP backing – with more than a half dozen provisional patents in process at the USPTO – and its innovative movement toward non-CBD cannabinoid production technology, suggesting the company will be at the vanguard of any move to establish the more exotic cannabinoids as commercial-scale markets.
One of the key moves made recently by the company is its venture into the alcohol substitute mixing space. According to its recent release, Hemp You Can Feel™ mixers are now available for online consumer purchase as well as bulk purchase for wholesale distribution. Cocktails based on the Hemp You Can Feel™ mixers provide an experience on par with light alcohol consumption, but without any of the harmful side effects of alcohol.
“Because of the ultra-low levels of hemp extracts utilized, we feel we set a new standard for product-safety and satisfaction in the hemp food and beverage category with this product,” commented Arman Tabatabaei, CEO of Cannabis Global. “While our Hemp You Can Feel™ beverages likely have the lowest hemp extract levels in the industry, we believe we provide a vastly superior positive effect upon use. We invite all consumers and alcohol industry participants to try what we see as the first viable alternative to alcoholic beverages. Our website is www.HempYouCanFeel.com. Take the HempYouCanFeel Challenge!”
Cannabis Global Inc (OTCMKTS:CBGL) believes the use of Hemp You Can Feel™ is significantly safer than the consumption of other hemp-based or high-cannabidiol (CBD) based beverages. Because of the natural water solubility of the preparations, only a minuscule amount of hemp extracts is present in the cocktail mixers. Laboratory analysis and results by High Performance Liquid Chromatography (HPLC) indicated the presence of hemp extracts in the non-detectable category.
Shares of CBGL are testing key support in recent action, and have a history of sharp runs off of support when challenged. We would also note that the company has been get more and more catalysts out in the public eye in recent weeks suggesting that something new and positive is usually on the way to fuel the next move.
Cannabis Global Inc (OTCMKTS:CBGL) had no reported sales in its last quarterly financial data. But it appears to be closing in on commercial-stage operational gains for shareholders and has a strong IP edge in the industry.
CBD of Denver Inc. (OTCMKTS:CBDD) is another less well-known name making strong strides in the space. The company engages in developing and commercializing cannabidiol (CBD) products. It is involved in the research, development, and distribution of premium hemp extract products. CBD of Denver Inc. operates as a subsidiary of Swiss Industry Ventures AG. CBDD is focused on using equity to acquire profitable Swiss assets at attractive valuations to create value for shareholders.
CBDD offers a superior CBD product that is full spectrum without depending on THC to activate the benefits of the cannabidiol. According to company materials, CBDD was created to offer the consumer a unique and new perspective on the unorganized and confusing CBD industry. CBD of Denver, Inc. is the only company to release a comprehensive CBD Social Network (www.cbdsocialnetwork.com). The idea of the network is to connect CBD users from America and around the world to interact and discuss CBD uses, treatments and products. The site has been active for 3 months and already receives 2000-2500 hits a day.
CBD of Denver Inc. (OTCMKTS:CBDD) just put out a recent announcement providing additional information on the revenue reported for Rockflowr, GmbH and CBD Welt 24, GmbH.
According to the release, revenue for Rockflowr and CBD Welt 24, subsidiaries of CBD of Denver, Inc., was reported in CBDD’s 2nd Quarter Disclosure with OTC Markets as of the date each company was acquired and not for their own full quarter. To provide context for the revenue numbers reported in CBDD’s quarterly statement, CBBD is providing the revenue generated by Rockflowr and CBD Welt24 for their full quarters and not just since they were acquired by CBDD in the middle of quarter.
Rockflower: For the period from April 1, 2020 through June 30, 2020 Rockflowr had revenue of 1,710,000.00 CHF or approximately $1,833,120.00 USD with net profits of 131,089 CHF or approximately $140,527 USD. CBD Welt 24: For the period from April 1, 2020 through June 30, 2020 CBD Welt24 had revenue of 56,500.00 CHF or approximately $60,568,00 with a net profit 45,416 CHF of approximately $48,686 USD. This amount only reflects revenue after the first harvest as it took two months from initial planting until first harvest to generate revenue. Moving forward, CBD Welt24 expects a harvest every month that should substantially increase revenue.
CBD of Denver Inc. (OTCMKTS:CBDD) just posted a net profit in Q2, which is the first time in the company’s history that it has achieved that milestone, which the company rightly sees as an indication of being on the right course in terms of providing value for its shareholders.
Charlotte’s Web Holdings Inc (OTCMKTS:CWBHF) develops and distributes hemp-based cannabidiol (CBD) wellness products. Its products include CBD hemp oils, capsules, topicals, and pet products that feature CBD hemp oil extracts. Charlotte’s Web Holdings, Inc. sells its products online as well as through distributors, and brick and mortar retailers.
Charlotte’s Web Holdings, Inc. is a market leader in the production and distribution of innovative hemp-based cannabidiol wellness products. Founded by the Stanley Brothers, the Company’s premium quality products start with proprietary hemp genetics that are responsibly manufactured into whole plant hemp extracts naturally containing a full spectrum of phytocannabinoids, including CBD, terpenes, flavonoids and other beneficial hemp compounds. Industrial hemp products are non-intoxicating.
Charlotte’s Web Holdings Inc (OTCMKTS:CWBHF) recently announced its “Trust The Earth” initiative, which is designed to democratize access to hemp-derived products for those seeking wellness and relief.
Studio Number One, a creative agency co-founded by artist Shepard Fairey, created the original artwork, first publicly exhibited by Charlotte’s Web as a mural in Brooklyn in October 2019. Today, Studio Number One’s original art is exhibited from the ground up, literally, as field art on a mammoth scale of 76-acres in America’s heartland.
Even in light of this news, CWBHF has had a rough past week of trading action, with shares sinking something like -5% in that time. That said, chart support is nearby, and we may be in the process of constructing a nice setup for some movement back the other way.
Charlotte’s Web Holdings Inc (OTCMKTS:CWBHF) pulled in sales of $28.9M in its last reported quarterly financials, representing top line growth of 0.1%. In addition, the company has a strong balance sheet, with cash levels far exceeding current liabilities ($75.5M against $42.2M).
This article is part of JournalTranscript.com Networks. Read the JournalTranscript.com Networks Disclaimer.
YOU MAY LIKE
?
?
Published at Mon, 10 Aug 2020 04:38:26 +0000
Tweet
Pin It
?
SUBSCRIBE
Get the latest content first.
We respect your privacy.
Stock Ticker
Market Data by TradingView
Recent News
?Study Finds Medical Cannabis Improves Seniors’ Quality Of Life
August 30, 2020 • No Comment
?2020828-news-Seed
August 30, 2020 • No Comment
?Need to Know: Mass CultivatED Educates, Trains Bay Staters Impacted by Prohibition
August 30, 2020 • No Comment
?Why Sugarmade Inc (OTCMKTS:SGMD) Could Find a Spotlight
August 30, 2020 • No Comment
?Pennsylvania Governor Calls for Adult-Use Cannabis Legalization, Nebraska Secretary of State Sends Medical Cannabis Initiative to November Ballot: Week in Review
August 29, 2020 • No Comment
Marijuana Stock Copyright © 2020.
https://www.cbdtoday.com/cbd-of-denver-inc-cbdd-extracting-and-selling-pollen
Article about CBDD from Thursday the 27th, sorry if this had already been posted here.
I got that same message from TDA this morning. First time seeing it. Went to my Etrade account and no problem.
How exactly do you know that him providing direction where to find a supposedly already publicly released ad would be in violation of the NDA? Have you read it? Makes no sense.
Excellent, thanks for updating us here on and taking your time to meet with him. Much appreciated ccret.
Proof of employment and access to professed information would be a good start.
Right? One showing proof/evidence, the other nothing. Interesting... lol
With ebay and such, you will be assessed a listing fee as well as a final value fee (sale fee) on top of the 3% PayPal fee. I would suggest just using PayPal. Can be handled two ways, 1st, post your PayPal email and people can send the purchase price to that email or 2nd which I suggest, anyone wanting a shirt provides you their PayPal email and you send them an invoice for payment through PayPal. This way is what i use for part of my PI business. Hope this helps.
Thanks for sharing that info. Much appreciated.
It really depends. If someone expresses an opinion as a fact, with the intent of influencing others’ thinking and actions, but without the facts (not just other opinions) to support it, it’s a lie, or at the very least propaganda.
Didn't even think of that. Appreciate it.
Sorry for my ignorance, but what is "rmb". Thanks
No, he is not. A different guy, same name.
Purposfully posted with the intent to deceive new investors.
That's a rather libelous statement to make publicly, got some documentation to prove embezzlement? Please post for all to see. Should be interesting.